1 / 36

National Subcutaneous Insulin Form Pilot

National Subcutaneous Insulin Form Pilot. <<< Insert name of Project Officer/Team >>> <<< Insert name of Hospital >>> A national pilot project supported by the Australian Commission on Safety and Quality in Health Care. Background. Insulin recognised internationally as a high risk drug

oded
Download Presentation

National Subcutaneous Insulin Form Pilot

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. National Subcutaneous Insulin Form Pilot <<< Insert name of Project Officer/Team >>> <<< Insert name of Hospital >>> A national pilot project supported by the Australian Commission on Safety and Quality in Health Care

  2. Background Insulin recognised internationally as a high risk drug Standardised Insulin prescribing and administration forms for adults have been implemented in Queensland Health hospitals since 2008 Need has been established for a nationally standardised form to accompany the National Inpatient Medication Chart (NIMC)

  3. Monitoring Communication and Safety Insulin Administration Insulin Orders

  4. Before you start • Cross reference the insulin form on the NIMC • Also cross reference in regular medication order to ensure that: • staff refer to the Insulin Subcutaneous Order • insulin is not omitted from discharge medications. • A sticker is available or

  5. Patient Identification • Affix the current patient identification label (with the consumer’s name printed underneath) • OR • As a minimum, the consumer’s name, UR number, address, date of birth and gender written in legible print

  6. Hospital Demographics • Complete Facility, Year and Ward / Unit

  7. Monitoring / Notification Instructions • Prescriber indicates theBGL Frequency of monitoring required • Default BGL monitoring for inpatients is Pre-meals and at 21:00hrs • Consider more frequent BGL monitoring if required

  8. Medical Officer to notify / Special Instructions The prescriber should document: • who to notify of out of range BGLs or other diabetes related concerns • any Special Instructions If no contact name is written, the treating prescriber or team will be notified • After hours the doctor on-call will be notified

  9. Diabetes treatment prior to admission • The prescriber, pharmacist or nursewrites the Diabetes treatment prior to admission in the space provided • may include oral diabetes medicines and/or insulin types and doses • optional additional information may include the insulin device that the patient was using

  10. Blood Glucose Level (BGL) Monitoring Section • Write the Dateat the top of the day’scolumn • Write the patient’s Diet • This prompts for re-assessment of insulin requirements should the patient be fasting for a procedure or be on a diet such as clear fluids

  11. BGL Monitoring Section • Write the Time the BGL is measured • Perform a BGL according to facility procedure • Write the BGL in the coloured corresponding with the relevant BGL range • Note and act on any ALERTinstructions in the BGL ranges

  12. ALERTS (1) If the BGL is less than 4 mmol/L • Initiate hypoglycaemia management (see page 4 of chart) • Notify the treating doctor or doctor on-call • Tick the Hypo Intervention and Dr Notified boxes • Perform follow up BGLs and respond accordingly • Document treatment and response on form and in medical record

  13. ALERTS (2) High ALERT ranges are: • BGL greater than 20 mmol/L • second consecutive BGL greater than 16 mmol/L • third consecutive BGL greater than 12 mmol/L If BGL is in one of the ALERT ranges: • Notify the treating prescriber or doctor on-call • Perform a ketone test (urine or blood), document result in the Ketones box • Document the actions taken in the medical record • Tick the Dr Notified box

  14. Insulin Orders (Prescribing) • A patient may be prescribed any combination of Routine, Supplemental, andStat / Phone Insulin Orders • If a patient with diabetes is not receiving subcutaneous insulin, this form should still be used for BGL monitoring

  15. Routine Insulin Orders (1) • Six (6) spaces to prescribe routine insulin • Four (4) spaces with Meal / time pre-printed • Breakfast • Lunch • Dinner • Pre-Bed • Use additional sections when a patient requires 2 insulin types at a single meal / time • Two (2) additional spaces without the pre-printed Meal / time

  16. Routine Insulin Orders (2) The prescriber must: • Write the type of insulin (full trade name) • Sign each order • Print their name in full at least once on the form • Write the date • Write the dose as a whole number • Units is pre printed as a watermark • Initials each dose ordered • initials is pre printed as watermark • Insulin doses must be ordered for each day • It is usually appropriate to also order doses for the following morning

  17. Routine Insulin Orders (3) • The prescriber should also write the full trade name of insulin type/s in the Administration Record

  18. Routine Insulin Orders (4) If routine insulin is ceased, the prescriber must: • Draw a line through the order • Write the reason for ceasingthe order, the date the order was ceased and initials • When the insulin regimen is being changed, write the new order on a new form Ceased. Changing to mixed insulin prior to discharge. See new chart

  19. Supplemental Insulin Orders (1) • It is not necessary to prescribe supplemental insulin for all patients • It might be considered for erratic BGLs where strict control is required • Patients may require supplemental insulin if: • their condition, dietary intake or concurrent medications are altering insulin requirements • optimal doses not yet determined • May be in addition to a routine mealtime or basal insulin dose

  20. Supplemental Insulin Orders (2) Prescribing • Tick the appropriate Frequency • Write the Name of insulin, start date and start time • Standardised BGL ranges are pre printed • if required, different BGL ranges may be used • Write insulin doses • suggested doses available in Table 1 (page 1) • Supplemental order remains valid until changed or ceased • Sign and initial the order • Review supplemental doses as required • Changes are validated by initialling changes in the corresponding column • Also write the Name of supplemental insulin in the Administration Record

  21. Stat / Phone Orders (1) Stat Orders • Document any single dose orders in this section • The prescriber must verbally inform the nurse responsible for the patient’s care of any stat orders

  22. Stat / Phone Orders (2) Phone Orders • For Phone Orders nurses document: • the Date the order is received • the Name of insulin • the dose (as a whole number) • Date / time the dose is to be administered • ‘phone order’ and the name of prescriber • the initials of the nurses who received the order • A second nurse must read back the written order to the doctor to confirm and then countersign the phone order • The nurses receiving the phone order must check to see if the stat / phone order replaces, or is in addition to, other insulin orders • Phone orders should be signed by the prescriber within 24 hours • The nurse also cross references the phone order in the Routine Insulin Orders

  23. Insulin Administration • If clinical judgement indicates that a prescribed dose should not be administered,notify the prescriber or on-call doctor to review • Write the code W for withheld and document the reason and the action taken in the clinical record

  24. Administering Routine Insulin • Mealtime insulin dosesare given immediately before the patient eats • Contact prescriber or doctor on-call if the patient has been receiving insulin and there is not a dose ordered for a meal / time • Calculate, prepare, check and administer dose in line with facility procedure • Document the time given • Document the dose administered in the row against the correct Name of routine insulin row in the Administration Record • Initial to acknowledge administering the dose • Patients may have additional orders for the same time - check for Supplemental and Stat / Phone insulin orders • Example next slide

  25. Administering Supplemental Insulin • Review supplemental insulin order and current BGL to determine if supplemental dose is required • Calculate total insulin dose required • May be in addition to routine insulin dose • Prepare, check and administer total insulin dose • Document the time given • Document the doses or routine and supplemental insulin separately in the Administration Record • Initial to acknowledge administration of the dose • Example next slide

  26. Administering Stat/ Phone Orders • Prepare, check and administer dose • Document the time given • Document the dose of stat / phone insulin administered in the row against the corresponding name of Routine insulin • Sign as having administered the dose • Cross reference phone orders in the Routine Insulin Orders section • Example next slide

  27. Comments Section • For the documenting communication between members of the treating team with regard to insulin therapy and diabetes management • Examples of what to document here include: • Doctor has been notified of the BGL • hypoglycaemic event has been treated • patient changed to intravenous insulin.

  28. Pharmacy Review • The clinician undertaking the pharmacy review will sign this section as a record that they have reviewed the insulin form (on the corresponding day) to ensure that all insulin orders are clear, safe and appropriate for that individual patient, therefore reducing the risk of an adverse drug event

  29. Guidelines for Managing Hyperglycaemia Alerts Have been included to assist inexperienced and non specialist clinicians with management of hyperglycaemia in hospital inpatients. They provide information related to: assessment required when called for a Hyperglycaemia Alert  initiation of basal and mealtime insulin and adjustment of insulin doses  suggested stat and supplemental doses based on weight or previous total daily dose. 1 2 3

  30. Management of Hypoglycaemia in Diabetes - Adult • Has four treatment pathways: • conscious and cooperative • insulin infusion • nil by mouth or nil by tube • oral or tube fed • Appropriate food choices are listed • Food choices should be centrally located in each ward / unit / outpatient facility • Each unit should have access to glucose 50% intravenous 50mL and glucagon 1mg injection to use in emergency situations • Glucose based products are preferred as initial treatment • Non diet products must be used to treat hypoglycaemia Larger example next slide

  31. Management of Hypoglycaemia in Diabetes - Adult

  32. Diabetes treatment review after hypoglycaemia • Below the flowchart are guidelines for Diabetes treatment review following treated hypoglycaemia • Diabetes management must be reviewed in response to a hypoglycaemic event

  33. Acknowledgement This work was developed by Medication Services Queensland of Queensland Health and is based on the user guide developed to support the State Insulin Subcutaneous Order and Blood Glucose Record for adults.

More Related